Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Has results × Leukemia, Neutrophilic, Chronic × In Situ Hybridization, Fluorescence × Clear all

Sponsor

Conditions

Waldenstrom Macroglobulinemia 4 Multiple Myeloma 4 Lymphoma, Mantle-Cell 4 Lymphoma, Follicular 4 Lymphoma, B-Cell, Marginal Zone 4 Leukemia, Lymphocytic, Chronic, B-Cell 4 Sezary Syndrome 3 Mycosis Fungoides 3 Lymphoma, Large-Cell, Anaplastic 3 Lymphoma, Large B-Cell, Diffuse 3 Lymphoma, Extranodal NK-T-Cell 3 Congenital Abnormalities 3 Burkitt Lymphoma 3 Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 2 Precursor Cell Lymphoblastic Leukemia-Lymphoma 2 Myeloproliferative Disorders 2 Lymphoma, T-Cell, Peripheral 2 Lymphoma, T-Cell, Cutaneous 2 Lymphoma, Non-Hodgkin 2 Lymphoma, Large-Cell, Immunoblastic 2 Leukemia, Myelomonocytic, Chronic 2 Leukemia, Myeloid, Acute 2 Leukemia, Monocytic, Acute 2 Leukemia, Megakaryoblastic, Acute 2 Leukemia, Erythroblastic, Acute 2 Leukemia 2 Immunoblastic Lymphadenopathy 2 Hodgkin Disease 2 Dendritic Cell Sarcoma, Interdigitating 2 Squamous Cell Carcinoma of Head and Neck 1

Interventions

fludarabine phosphate 9 Cyclophosphamide 7 Busulfan 7 Antilymphocyte Serum 7 Whole-Body Irradiation 6 Peripheral Blood Stem Cell Transplantation 6 Mycophenolic Acid 6 Tacrolimus 5 Methotrexate 5 Cyclosporine 5 thymoglobulin 4 Melphalan 4 Rituximab 3 Etoposide 3 Cord Blood Stem Cell Transplantation 3 Sirolimus 2 Radiotherapy 2 Ondansetron 2 Granulocyte Colony-Stimulating Factor 2 Dexamethasone 2 Cytarabine 2 Carmustine 2 Calcium Dobesilate 2 Aprepitant 2 ruxolitinib 1 etoposide phosphate 1 dexamethasone acetate 1 dexamethasone 21-phosphate 1 carmustine, poliferprosan 20 drug combination 1 Sugars 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡